$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000107997322001425 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$607.5K	$866.5K	$491.1K
YoY Change	-1.69%	76.43%	62.15%
% of Gross Profit
Research & Development	$15.15K	$28.44K	$61.81K
YoY Change	-72.15%	-53.98%	-32.07%
% of Gross Profit
Depreciation & Amortization	$394.00	$330.00	$250.00
YoY Change	19.39%	32.0%	20.77%
% of Gross Profit
Operating Expenses	$646.1K	$895.3K	$553.2K
YoY Change	-3.96%	61.84%	40.38%
Operating Profit	-$646.1K	-$895.3K	-$553.2K
YoY Change	-3.96%	61.84%
Interest Expense	$85.29K	$26.10K	-$110.7K
YoY Change	-172.83%	-123.57%	6.09%
% of Operating Profit
Other Income/Expense, Net	-$83.91K	-$24.16K	-$110.7K
YoY Change	-100.83%	-78.17%
Pretax Income	-$730.0K	-$919.4K	-$663.9K
YoY Change	-107.73%	38.49%	33.2%
Income Tax
% Of Pretax Income
Net Earnings	-$730.0K	-$919.4K	-$663.4K
YoY Change	-107.73%	38.6%	33.1%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02	-$0.02
Diluted Earnings Per Share	-$0.02	-$21.16K	-$16.29K
COMMON SHARES
Basic Shares Outstanding	43.63M shares	43.42M shares
Diluted Shares Outstanding	43.62M shares	43.45M shares	40.72M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.101M	$1.898M	$3.962M
YoY Change	-77.74%	-52.1%	1078.88%
Cash & Equivalents	$1.101M	$1.898M	$3.962M
Short-Term Investments
Other Short-Term Assets	$78.49K	$135.3K	$91.30K
YoY Change	64.48%	48.14%	410.06%
Inventory
Prepaid Expenses	$77.49K	$134.3K
Receivables
Other Receivables
Total Short-Term Assets	$1.180M	$2.033M	$4.054M
YoY Change	-76.38%	-49.84%	1045.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.836M	$3.249M	$62.58K
YoY Change	1103.56%	5091.13%	5290.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.956M	$3.381M	$62.58K
YoY Change	1141.22%	5303.47%	5290.18%
TOTAL ASSETS
Total Short-Term Assets	$1.180M	$2.033M	$4.054M
Total Long-Term Assets	$3.956M	$3.381M	$62.58K
Total Assets	$5.136M	$5.415M	$4.116M
YoY Change	-3.36%	31.55%	1058.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$523.3K	$549.4K	$214.2K
YoY Change	146.52%	156.46%	-66.98%
Accrued Expenses			$950.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$9.939M
YoY Change		-100.0%	2.7%
Total Short-Term Liabilities	$1.237M	$1.204M	$11.18M
YoY Change	24.94%	-89.24%	-0.25%
LONG-TERM LIABILITIES
Long-Term Debt	$5.300M	$5.212M	$4.893M
YoY Change	4.42%	6.53%	5.32%
Other Long-Term Liabilities	$135.4K	$132.1K
YoY Change	10.46%
Total Long-Term Liabilities	$5.435M	$5.344M	$4.893M
YoY Change	4.56%	9.22%	5.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.237M	$1.204M	$11.18M
Total Long-Term Liabilities	$5.435M	$5.344M	$4.893M
Total Liabilities	$6.673M	$6.548M	$16.12M
YoY Change	7.17%	-59.37%	1.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$125.7M	-$125.0M
YoY Change
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.574M	-$1.171M	-$12.00M
YoY Change
Total Liabilities & Shareholders Equity	$5.136M	$5.415M	$4.116M
YoY Change	-3.36%	31.55%	1058.94%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$730.0K	-$919.4K	-$663.4K
YoY Change	-107.73%	38.6%	33.1%
Depreciation, Depletion And Amortization	$394.00	$330.00	$250.00
YoY Change	19.39%	32.0%	20.77%
Cash From Operating Activities	-$606.0K	-$1.316M	-$350.0K
YoY Change	20.48%	275.97%	41.58%
INVESTING ACTIVITIES
Capital Expenditures	$416.8K	$322.7K	-$7.490K
YoY Change	-592.44%	-4408.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$416.8K	-$322.7K	-$7.490K
YoY Change	392.44%	4208.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	226.2K	$376.1K	103.5K
YoY Change	-85.62%	263.41%	360.0%
NET CHANGE
Cash From Operating Activities	-606.0K	-$1.316M	-350.0K
Cash From Investing Activities	-416.8K	-$322.7K	-7.490K
Cash From Financing Activities	226.2K	$376.1K	103.5K
Net Change In Cash	-796.5K	-$1.262M	-254.0K
YoY Change	-180.79%	397.05%	13.03%
FREE CASH FLOW
Cash From Operating Activities	-$606.0K	-$1.316M	-$350.0K
Capital Expenditures	$416.8K	$322.7K	-$7.490K
Free Cash Flow	-$1.023M	-$1.639M	-$342.5K
YoY Change	144.49%	378.41%	38.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q2	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2021Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2021Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022Q3	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
CY2021Q3	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021Q3	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable		usd
CY2021Q3	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable		usd
CY2021Q3	bnet	Conversion Of Notes Payable Into Shares ConversionOfNotesPayableIntoShares		usd
CY2021Q3	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment		usd
CY2022Q3	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions		usd
CY2022Q3	bnet	Shares Issued For Accounts Payable SharesIssuedForAccountsPayable		usd
CY2022Q3	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable		usd
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross		usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	000-19333
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	Bion Environmental Technologies, Inc
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
CY2022Q3	dei	City Area Code CityAreaCode	516
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	586-5643
CY2022Q3	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q3	dei	Trading Symbol TradingSymbol	BNET
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43625575	shares
CY2022Q3	us-gaap	Cash Cash	1897981	usd
CY2022Q2	us-gaap	Cash Cash	3160442	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	134253	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	157550	usd
CY2022Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	2033234	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3318992	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132881	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145787	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3248610	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2895558	usd
CY2022Q3	us-gaap	Assets Assets	5414725	usd
CY2022Q2	us-gaap	Assets Assets	6360337	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	549425	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1360644	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	654349	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	594798	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1203774	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1955442	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	132113	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128864	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5212286	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5170610	usd
CY2022Q3	us-gaap	Liabilities Liabilities	6548173	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7254916	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44303654	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43758820	shares
CY2022Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	43599345	usd
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	43054511	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	124300604	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123620046	usd
CY2022Q3	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124966975	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124047548	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1171021	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-932152	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1133448	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5414725	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6360337	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	866494	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	491133	usd
CY2022Q3	us-gaap	Depreciation Depreciation	330	usd
CY2021Q3	us-gaap	Depreciation Depreciation	248	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28443	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61809	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	895267	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	553190	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-895267	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-553190	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	1935	usd
CY2021Q3	us-gaap	Interest Income Operating InterestIncomeOperating	1494	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	26095	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	112180	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-24160	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-110686	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-919427	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-663876	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-506	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-919427	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-663370	usd
CY2022Q3	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.02
CY2021Q3	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.02
CY2022Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	43451846	shares
CY2021Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	40719692	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11406339	usd
CY2021Q3	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	104500	usd
CY2021Q3	bnet	Commissions On Warrant Exercises CommissionsOnWarrantExercises	-1000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5126	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-663876	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11961589	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2022Q3	bnet	Sale Of Units Value SaleOfUnitsValue	320000	usd
CY2022Q3	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	56125	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	15000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	50000	usd
CY2022Q3	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	159433	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-919427	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1133448	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-919427	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-663876	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	330	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	248	usd
CY2022Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	26096	usd
CY2021Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	121111	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	154933	usd
CY2022Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	95000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-23297	usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-33753	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-787276	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	59367	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	16155	usd
CY2022Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	75000	usd
CY2021Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	99400	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1315892	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-349997	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	322694	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7490	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-322694	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7490	usd
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	56125	usd
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	104500	usd
CY2021Q3	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	1000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1737000	usd
CY2022Q3	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	320000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	376125	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	103500	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1262461	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-253987	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4216321	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1897981	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3962334	usd
CY2022Q3	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
CY2022Q3	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	20000	usd
CY2022Q3	bnet	Conversion Of Notes Payable Into Shares ConversionOfNotesPayableIntoShares	50000	usd
CY2022Q3	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	30688	usd
CY2021Q3	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	7500	usd
CY2021Q3	bnet	Shares Issued For Accounts Payable SharesIssuedForAccountsPayable	5126	usd
CY2021Q3	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	54800	usd
CY2022Q3	bnet	Cattle Per Head CattlePerHead	300	decimal
CY2022Q3	bnet	Techwastage Techwastage	1500	decimal
CY2022Q3	bnet	Percentage Of Sustainable PercentageOfSustainable	0.295	pure
CY2022Q3	bnet	Description Of Kreider2 Poultry Project DescriptionOfKreider2PoultryProject	Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) ('Kreider Renewable Energy Facility' or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3 Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA).
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3451000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8292000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10235000	usd
CY2022	bnet	Gain On Sale Of Domain Amount GainOnSaleOfDomainAmount	902490	usd
CY2022Q3	bnet	Operating Loss OperatingLoss	919000	usd
CY2021Q3	bnet	Operating Loss OperatingLoss	663000	usd
CY2022Q3	bnet	Working Capital WorkingCapital	1171000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1171021	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5209000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	376000	usd
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zhCldYSRz2Ba" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zXyeBee8OZx4">Concentrations of credit risk</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
CY2021Q3	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	41315986	shares
CY2022Q3	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
CY2021Q3	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
CY2022Q3	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
CY2021Q3	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	40611677	shares
CY2022Q3	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	397335	shares
CY2021Q3	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	108015	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43451846	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40719692	shares
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z3EaJNUzrHZ1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zPoK3X2XOqZd">Use of estimates</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2022Q3	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	13598	usd
CY2022Q2	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	13598	usd
CY2022Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3245604	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2892222	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3259202	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2905820	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10592	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10262	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3248610	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2895558	usd
CY2022Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	62688	usd
CY2022Q3	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2022Q3	us-gaap	Depreciation Depreciation	330	usd
CY2021Q3	us-gaap	Depreciation Depreciation	248	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	654349	usd
CY2021Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	528640	usd
CY2022Q3	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04	pure
CY2022Q3	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17612151	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Assets Assets	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2022Q3	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	30688	usd
CY2021Q3	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
CY2022Q3	bnet	Redemption Of Convertible Preferred Stock RedemptionOfConvertiblePreferredStock	41000	usd
CY2022Q3	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309	shares
CY2022Q3	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	74834	shares
CY2022Q3	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	74834	shares
CY2022Q3	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	56125	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.60
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2022Q3	bnet	Sale Of Unit Price Per Unit SaleOfUnitPricePerUnit	1.00
CY2022Q3	us-gaap	Share Price SharePrice	0.75
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	320000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	320000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20600000	shares
CY2022Q2	bnet	Sharebased Compensation Granted SharebasedCompensationGranted	720000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4429263	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y5M23D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5757755	usd
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
CY2022Q2	bnet	Compensation Increased CompensationIncreased	25000	usd
CY2021Q3	bnet	Exercise Bonus ExerciseBonus	0.75	pure
CY2022Q3	bnet	Warrants Held By Trust Owned WarrantsHeldByTrustOwned	3000000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M29D
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q3	bnet	Aggregate Payment AggregatePayment	1999125	usd
CY2022Q1	bnet	Sale Of Domain Description SaleOfDomainDescription	the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4	us-gaap	Long Term Construction Loan Current LongTermConstructionLoanCurrent	10010000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2255802	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Assets Assets	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10234501	usd
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	43750	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	75000	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	31250	usd
CY2022Q3	bnet	Undiscounted Cash Flow UndiscountedCashFlow	150000	usd
CY2022Q3	bnet	Less Imputed Interest LessImputedInterest	-17888	usd
CY2022Q3	us-gaap	Capital Leases Contingent Rental Payments Due CapitalLeasesContingentRentalPaymentsDue	132112	usd

Files In Submission

Name	View Source	Status
0001079973-22-001425-index-headers.html	Edgar Link	pending
0001079973-22-001425-index.html	Edgar Link	pending
0001079973-22-001425.txt	Edgar Link	pending
0001079973-22-001425-xbrl.zip	Edgar Link	pending
bion_10q-093022.htm	Edgar Link	pending
bion_ex31z1.htm	Edgar Link	pending
bion_ex31z2.htm	Edgar Link	pending
bion_ex32z1.htm	Edgar Link	pending
bion_ex32z2.htm	Edgar Link	pending
bnet-20220930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
bnet-20220930_lab.xml	Edgar Link	unprocessable
bnet-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bnet-20220930_cal.xml	Edgar Link	unprocessable
bnet-20220930_def.xml	Edgar Link	unprocessable
bion_10q-093022_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2022 Q4 Form 10-Q Financial Statement

#000107997322001425 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2022 Q4 Form 10-Q Financial Statement

#000107997322001425 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet